期刊文献+

单侧髋关节置换术患者手术前后外周血中OPG与RANKL浓度对比分析

Comparison of OPG and RANKL Levels in Peripheral Blood Between Before and after Hemi-hip Replacement Surgery
原文传递
导出
摘要 [目的]探讨老年患者(≥65岁)单侧髋关节术后短期内骨代谢变化.[方法]收集单侧髋关节置换手术患者术前后18例外周血液,采用ELISA法检测血清中骨保护素(OPG)、核激活因子受体配体(RANKL)手术前后浓度,分析OPG、RANKL表达水平变化.[结果]单侧18例行髋关节置换术患者术后OPG浓度均较术前明显增加,而16例患者术后RANKL浓度均明显下降,其中2例患者术后RANKL浓度轻度增加,术后患者RANKL/OPG比值总体下降.[结论]老年患者单侧髋关节术后OPG浓度增加和RANKL浓度的下降,导致RANKL/OPG比值总体下降,提示此类患者其术后短期内破骨功能可能受抑制而成骨功能却明显增强. [Objective]To explore bone metabolism changes in elderly patients(≥65 years old) after hemi-hip replacement surgery.[Methods] The peripheral blood samples of 18 patients before and after hemi-hip replacement surgery were collected.ELISA was used to detect serum levels of osteoprotegerin(OPG) and receptor activator of NF-κB ligand (RANKL) before and after operation.The change of OPG and RANKL was analyzed.[Results] Compared with before operation,OPG level in 18 patients undergoing hip replacement after operation was obviously increased,but RANKL level in 16 patients after operation was obviously decreased and RANKL level in 2 patients after operation was slightly increased.The total ratio of RANKL/OPG after operation was decreased.[Conclusion]The OPG level in elderly patients after hemi-hip replacement surgery is increased and RANKL level is decreased,which leads to the decreasing of RANKL/OPG.It suggests that osteoclast function in these patients may be inhibited but osteoblast function is obviously increased after operation in short term.
出处 《医学临床研究》 CAS 2014年第9期1687-1689,共3页 Journal of Clinical Research
基金 湖南省科技厅自然科学研究一般项目(06FJ3114)
关键词 关节成形术 置换 骨保护素/血液 NF-κB/血液 膜糖蛋白类/血液 破骨细胞 成骨细胞 Arthroplasty, Replacement, Hip Osteoprotegerin/BL NF-kappa B/BL Membrane Glycoproteins/BL Osteoclasts Osteoblasts
  • 相关文献

参考文献9

二级参考文献105

  • 1樊新甫,杨凤云,董英海.人工关节置换术后的骨吸收和骨溶解[J].临床骨科杂志,2006,9(1):92-94. 被引量:5
  • 2高坤,镐英杰,张晖,裴福兴.靶向RANKL基因的siRNA对成骨细胞促破骨细胞生成作用的影响[J].四川医学,2007,28(6):575-577. 被引量:3
  • 3Greenfield EM, Bechtold J, Implant Wear Sympium 2007 Biologic Work Group. What other biologic and mechanical factors night contribute to osteolysis? J Am Acad Orthop Surg, 2008; 16(Suppl 1):S56-S62.
  • 4Hoeuauer LC, Heufelder AE. Osteoprotegerin ligand and osteoprotegerin: new concepts of the pathogenesis and therapy of metabolic bone diseases. Dtsch Med Wochenschr, 2001 ; 126(6) : 145-150.
  • 5Dehm SM, Bonham K SRC gene expression in human cancer: the role of transcriptional activations. Biochem Cell Biol. 2004; 82(2):263-274.
  • 6Yang S, Glen W, Stashenko P, et al. Specificity of RGS10A as a key component in the RANKI. signaling mechanism for osteoclast differentiation. J Cell Sci, 2007; 120(Pt 19) :3362-3371.
  • 7Sobacchi C, Frattini A, Guerrini MM, et al. Osteoclast-poor human osteopetrosis due to mutalions in the gene encoding RANKL Nat Genet, 2007; 39(8) : 960-962.
  • 8Nakamichi Y, Udagawa N, Kobayashi Y, et al. Osteoprotegerin reduces the serum level of receptor activator of NF-kappaB ligand derived from osteoblasts. J Immunol, 2007; 178(1):102-200.
  • 9Whyte MP, Obrecht SE, Finnegan PM, et al. Osteoprotegerin deficiency and juvenile Paget's disease. N Engl J Med, 2002,347(3):175-184.
  • 10Ren W, Wu B, Peng X, et al. Erythmmycin inhibits wear debris-induced inflammatory osteolysis in a murine model. J Orthop Res, 2006; 24(2):280-290.

共引文献61

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部